GPT and metabolic dysfunction-associated steatotic liver disease: In our study, SRD-fed rats exhibited significantly higher levels of triglycerides, cholesterol, liver damage markers (AST, ALT, and AP), elevated activity of enzymes involved in de novo lipogenesis and reduced CPT-1 activity, a marker of impaired fatty acid oxidation in NAFLD.